Director's Dealing • Feb 1, 2018
Director's Dealing
Open in ViewerOpens in native device viewer
Transfer of shares to CEO Medistim ASA
Medistim ASA has transferred 12,500 shares to Medistim CEO Kari Krogstad. It is part of her agreement with the Board of Medistim that she receives 12,500 shares. The agreement has been previously described in the Company's Annual Report. Medistims last traded share price in 2017 was 72.00 so the shares are transferred at this cost.
Medistim ASA has 176,000 own shares and a after the transfer to Kari Krogstad the company has 163,500 own shares shares. Kari Krogstad has after the latest transfer 112,500 shares in Medistim ASA.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.